It's an upgrade worth making, but it comes down to your privacy concerns.
11don MSNOpinion
I managed through four tech disruptions at HBO. ‘AI Minimalism’ is the secret to survival in the fifth disruption
Covering more ground faster creates better outcomes only if you know which direction to run. Over the course of my career, ...
Agentic AI represents an opportunity for shared global development as it can become a tool for leapfrogging legacy digital ...
On the evening of July 10, AI investor Matt Shumer posted a terse, furious message to X: GPT-5.6 Sol had just accidentally deleted nearly all the files on his Mac ...
The latest generation of AI models are such competent coders, engineers and (soon) scientists that many worry they may be among the last ever made by humans.
On July 4, 2026, Vitalik Buterin published the most consequential Ethereum protocol document in four years: an updated "Lean Ethereum" strawmap that commits the world's second-largest blockchain to ...
OpenAI and Broadcom unveiled Jalapeño, a custom AI inference chip designed in nine months. Early tests show 50% cost savings over standard GPUs, with deployment planned for late 2026.
Investor's Business Daily on MSN
AI stocks: Will self-improving models decide who wins superintelligence race?
Self-improving models are reshaping the AI race as OpenAI, Anthropic, Google and others pursue superintelligence.
Learn the important Racket concepts with practical examples, from functions and recursion to macros, contracts, streams, and ...
Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about ...
Cathie Wood's Ark Genomic Revolution ETF owns $50 million worth of Recursion Pharmaceuticals stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results